Research Paper Volume 15, Issue 24 pp 15360—15381
Clinical and therapeutical significances of the cluster and signature based on oxidative stress for osteosarcoma
Figure 6. Immunotherapy and chemotherapy of OXS-signature for TARGET-OS. (A) Comparison of the ICB response rates between groups with high OS-scores or low OS-scores; (B) SubMap analysis for OXS-signature in TARGET-OS; (C) Box plots of estimated IC50 for six chemotherapeutic agents in high- or low-OS-score groups, with green images representing the group with higher OS-scores, and purple images representing the group with lower OS-scores.